Researchers open new routes to treat asthma attacks

May 2, 2017 by Ryan O'hare, Imperial College London
Credit: Imperial College London

Research into the mechanism behind asthma attacks has discovered potential new ways to treat - and possibly prevent - this life-threatening condition.

Most attacks happen when people catch a cold – but exactly why the virus triggers an attack.

Researchers from the UK and Belgium have discovered a new pathway within the immune system that triggers an attack, and they believe some drugs already licensed or in development could be used to block various points on the pathway. One of these is commonly used to treat cystic fibrosis. Their findings are published today in Nature Medicine.

The body has two types of immune responses: type-1 responds to viruses and type-2 to allergens. In theory, when one response is triggered it should suppress the other, so catching a cold should prevent the allergic response that causes asthma. But in reality, the opposite happens, with colds being the highest risk factor for an .

The researchers, from Imperial College London and the University of Liège, wanted to see if a type of DNA, released as cells die during a cold infection, could be causing the type-2 response that creates inflammation of the airways, leading to asthma attacks.

They tested the theory by analysing nasal samples taken from 11 healthy individuals and 23 with asthma, before, during and after infection with a . They found that proteins linked to a type-2 immune response were higher in individuals with asthma after they were infected with the virus, and those individuals also had higher levels of the double-stranded DNA (dsDNA) which is released as the cells die.

Professor Sebastian Johnston, lead author from National Heart & Lung Institute at Imperial College London, said: "Our study in human volunteers showed that a cold infection did lead to extra dsDNA in the airways of people with asthma and an increased allergic response, but to prove the two were connected, we had to see whether getting rid of this dsDNA, or preventing its release, would reduce the allergic response."

The study in more detail

In order to test the connection between dsDNA and the in mice, the researchers used an enzyme called DNase, which digests excess DNA. DNase, known by the generic name dornase alfa, is a drug used in cystic fibrosis to thin the thick mucus which clogs up the lungs.

They found that mice treated with the enzyme had a lower type-2 response following infection with the cold virus, and also showed lower levels of inflammation in the airways.

They also showed that a cell type called neutrophils were releasing the dsDNA.Depleting numbers of these cells before infection, or blocking their release of the dsDNA, led to similar benefits as using DNase.

Professor Johnston, explained: "Reducing the release of dsDNA does reduce the type-2 immune response and the resulting inflammation, so new drugs to reduce neutrophil numbers in the lung, or to prevent the neutrophils from releasing their DNA could help prevent attacks. Speeding up clearance of the DNA once it is released has a similar effect, which means DNase could also work to prevent and hasten recovery from attacks occurring when people catch a cold. Because the enzyme is already licensed for , it should be possible to move fairly quickly to clinical trials, to see if we can replicate our success in the lab to reduce asthma attacks in patients."

The team also plan to work with companies who have drugs capable of reducing the number of neutrophils and limiting their capacity to release the excess dsDNA, which could stop asthma attacks at an earlier stage in the process.

Explore further: Study finds potential new target to treat asthma attacks brought on by colds

More information: Marie Toussaint et al. Host DNA released by NETosis promotes rhinovirus-induced type-2 allergic asthma exacerbation, Nature Medicine (2017). DOI: 10.1038/nm.4332

Related Stories

Study finds potential new target to treat asthma attacks brought on by colds

October 1, 2014
Researchers have identified a molecular mechanism that could explain why the common cold can bring on life-threatening asthma attacks.

Scientists discover peptide that could reduce the incidence of RSV-related asthma

February 1, 2017
A research report published in the Journal of Leukocyte Biology shows that it may one-day be possible to reduce the incidence of asthma related to infection with respiratory syncytial virus (RSV). Specifically, the researchers ...

Many students reluctant to use asthma inhalers at school

April 22, 2017
(HealthDay)—The thought of having to pull out an inhaler in the middle of school might stop some kids with asthma from breathing better, a study of British schoolchildren suggests.

Asthma in many adolescents is not an allergic disease

January 13, 2016
New research indicates that asthma in many adolescents is not likely to involve inflammation of the airways and therefore should not be considered an allergic disease.

Heightened immunity to colds makes asthma flare-ups worse, research shows

June 16, 2011
People often talk about "boosting" their immunity to prevent and fight colds. Nutritional supplements, cold remedies and fortified foods claim to stave off colds by augmenting the immune system.

New target could help to reduce symptoms of asthma attacks, research shows

March 8, 2016
An international team of researchers from the Universities of Leicester and Naples has examined the role of a receptor in the body that could help to prevent or reduce the effects of asthma attacks.

Recommended for you

Research team diagnoses asthma with nasal brush test

June 11, 2018
Mount Sinai researchers have identified a genetic biomarker of asthma that can be tested for using a simple nasal brush and basic follow-up data analysis. This inexpensive diagnostic test can accurately identify mild to moderate ...

Eosinophilic esophagitis may be due to missing protein

June 7, 2018
Scientists have discovered that the absence of a specific protein in cells lining the esophagus may cause inflammation and tissue damage in people with eosinophilic esophagitis (EoE). EoE affects as many as 150,000 people ...

Mouse study links triclosan, a common antimicrobial, to colonic inflammation

May 30, 2018
A large research team led by senior author Guodong Zhang at the University of Massachusetts Amherst reports that the antimicrobial ingredient triclosan, found in hand soaps and toothpastes among other products, could have ...

Body knows best: A natural healing mechanism for inflammatory bowel disease

May 30, 2018
Treating inflammatory diseases of the bowel is extremely challenging: Genes, gut microbes and disrupted immune function all contribute. Weizmann Institute of Science researchers are proposing a way around this complexity. ...

Chance discovery links inflammatory bowel disease with common bacterial gut toxin

May 17, 2018
New research has uncovered a surprise link between a common bacterial toxin found in the gut and inflammatory bowel disease (IBD).

New cytokine network can repair tissue damage in the intestine, study finds

May 16, 2018
A new group of proteins called cytokines, critical for antimicrobial activity and repairing the damaged intestinal tissue found in inflammatory bowel disease (IBD), has been discovered by researchers in a study led by Georgia ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.